FDA.reportPublic FDA data

amifampridine 10 MG Oral Tablet [Firdapse]

RxCUI
2107518
RxNorm name
amifampridine 10 MG Oral Tablet [Firdapse]
Display name
amifampridine 10 MG Oral Tablet [Firdapse]
Full name
amifampridine 10 MG Oral Tablet [Firdapse]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FirdapseAMIFAMPRIDINE PHOSPHATECatalyst Pharmaceuticals, Inc.f015fe60-3128-4a43-8c31-19fc6b5def3f2026-04-16Warnings, Adverse reactionsExact identifier
rxcui: 2107518

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f015fe60-3128-4a43-8c31-19fc6b5def3fFirdapse 10 MG Oral Tablet [PSN] · amifampridine 10 MG Oral Tablet [Firdapse] [SBD] · Firdapse 10 MG (as amifampridine phosphate 18.98 MG) Oral Tablet [SY]315These highlights do not include all the information needed to use FIRDAPSE ® safely and effectively. See full prescribing information for FIRDAPSE ® . FIRDAPSE ® (amifampridine) tablets, for oral use Initial U.S. Approval: 201820260416